David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Revolve Group
RVLV
$1.7B
| $25.9M | 0.03% |
575,495
+485,350
| +538% | +$19.8M |
|
727
Veritone
VERI
$86M
| $25.8M | 0.02% |
1,076,279
+297,830
| +38% | +$10.6M |
|
|
SPLK
728
PUT
DELISTED
Splunk Inc
SPLK
| $25.8M | 0.02% |
190,500
+61,500
| +48% | +$9.59M |
|
729
TG Therapeutics
TGTX
$8.57B
| $25.8M | 0.02% |
535,001
-333,478
| -38% | -$16M |
|
730
HF Sinclair
DINO
$16.9B
| $25.7M | 0.02% |
717,647
-907,904
| -56% | -$30.3M |
|
|
LL
731
DELISTED
LL Flooring Holdings, Inc.
LL
| $25.7M | 0.02% |
1,021,812
+126,718
| +14% | +$3.51M |
|
732
G-III Apparel Group
GIII
$1.43B
| $25.6M | 0.02% |
850,554
-331,503
| -28% | -$9.66M |
|
733
Insmed
INSM
$27.1B
| $25.5M | 0.02% |
749,809
-252,688
| -25% | -$9.66M |
|
734
PUT
Paycom
PAYC
$10.3B
| $25.5M | 0.02% |
68,800
-47,400
| -41% | -$18.7M |
|
735
PUT
Futu Holdings
FUTU
$16.2B
| $25.4M | 0.02% |
+160,000
| New | +$19.8M |
|
736
Citigroup
C
$221B
| $25.3M | 0.02% |
348,021
-5,488,331
| -94% | -$366M |
|
737
Strategy Inc
MSTR
$48.7B
| $25.3M | 0.02% |
372,500
-58,410
| -14% | -$4.13M |
|
738
Fate Therapeutics
FATE
$292M
| $25.2M | 0.02% |
306,238
-89,919
| -23% | -$8.62M |
|
739
Editas Medicine
EDIT
$461M
| $25.2M | 0.02% |
600,808
-808,285
| -57% | -$46M |
|
740
CALL
Apple
AAPL
$4.53T
| $25.2M | 0.02% |
206,200
-523,200
| -72% | -$67.2M |
|
|
VRN
741
DELISTED
Veren
VRN
| $25.1M | 0.02% |
6,026,115
+3,107,100
| +106% | +$11M |
|
742
Sun Communities
SUI
$15B
| $25.1M | 0.02% |
167,360
+59,846
| +56% | +$8.84M |
|
|
BPMC
743
DELISTED
Blueprint Medicines
BPMC
| $25.1M | 0.02% |
257,742
-19,892
| -7% | -$1.99M |
|
744
TransDigm Group
TDG
$66.3B
| $25M | 0.02% |
42,512
-30,274
| -42% | -$17.8M |
|
745
PUT
Vale
VALE
$64B
| $25M | 0.02% |
1,437,900
-202,100
| -12% | -$3.53M |
|
746
Clear Channel Outdoor Holdings
CCO
$1.2B
| $25M | 0.02% |
13,875,168
-3,689,826
| -21% | -$6.99M |
|
|
FBC
747
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $24.9M | 0.02% |
551,513
+247,981
| +82% | +$11.2M |
|
748
Shutterstock
SSTK
$198M
| $24.8M | 0.02% |
278,863
-70,377
| -20% | -$5.63M |
|
|
AVTA
749
DELISTED
Avantax, Inc. Common Stock
AVTA
| $24.8M | 0.02% |
1,491,357
-5,823
| -0.4% | -$97.7K |
|
750
PUT
Cloudflare
NET
$99.8B
| $24.8M | 0.02% |
353,000
+18,000
| +5% | +$1.39M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.